FDA Inspection 1074132 — National Genetics Institute

National Genetics Institute — FEI 3003082450

The FDA completed an inspection of National Genetics Institute on December 4, 2018 in Los Angeles, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
December 4, 2018
Fiscal Year
2019
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Los Angeles, CA (United States)